ATE223904T1 - Nitronderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen - Google Patents
Nitronderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE223904T1 ATE223904T1 AT99401565T AT99401565T ATE223904T1 AT E223904 T1 ATE223904 T1 AT E223904T1 AT 99401565 T AT99401565 T AT 99401565T AT 99401565 T AT99401565 T AT 99401565T AT E223904 T1 ATE223904 T1 AT E223904T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- pharmaceutical compositions
- compositions containing
- nitrone
- arylalkyl
- Prior art date
Links
- SQDFHQJTAWCFIB-UHFFFAOYSA-N n-methylidenehydroxylamine Chemical class ON=C SQDFHQJTAWCFIB-UHFFFAOYSA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000004446 heteroarylalkyl group Chemical group 0.000 abstract 2
- 150000002460 imidazoles Chemical class 0.000 abstract 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000005140 aralkylsulfonyl group Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 1
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9808116A FR2780404B1 (fr) | 1998-06-26 | 1998-06-26 | Nouveaux derives de nitrone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE223904T1 true ATE223904T1 (de) | 2002-09-15 |
Family
ID=9527896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99401565T ATE223904T1 (de) | 1998-06-26 | 1999-06-24 | Nitronderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6034250A (de) |
| EP (1) | EP0967207B1 (de) |
| JP (1) | JP2000026428A (de) |
| CN (1) | CN1153766C (de) |
| AT (1) | ATE223904T1 (de) |
| AU (1) | AU747203B2 (de) |
| BR (1) | BR9903282A (de) |
| CA (1) | CA2274621C (de) |
| DE (1) | DE69902851T2 (de) |
| DK (1) | DK0967207T3 (de) |
| ES (1) | ES2183492T3 (de) |
| FR (1) | FR2780404B1 (de) |
| HU (1) | HUP9902199A1 (de) |
| NO (1) | NO312722B1 (de) |
| NZ (1) | NZ336460A (de) |
| PT (1) | PT967207E (de) |
| ZA (1) | ZA994201B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096899A (en) * | 1998-04-14 | 2000-08-01 | The Regents Of The University Of Michigan | Cylic imidazole compounds having relatively low hydrogen content and relatively high nitrogen content and polymers formed therefrom |
| AU2002233643B2 (en) * | 2001-02-16 | 2007-07-26 | Asubio Pharma Co., Ltd. | Methods of treating diseases in association with decrease in the expression of AOP-1 gene or AOP-1 and remedies for the diseases |
| WO2003010154A1 (en) * | 2001-07-26 | 2003-02-06 | Samsung Electronics Co. Ltd. | Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses |
| DK1482931T3 (da) * | 2002-03-05 | 2011-12-19 | Transtech Pharma Inc | Mono- og bicycliske azolderivater der inhiberer interaktionen af ligander med RAGE |
| WO2003082216A2 (en) * | 2002-03-28 | 2003-10-09 | Oxis International, Inc. | Neuroprotectant methods, compositions, and screening methods thereof |
| WO2005000295A1 (en) * | 2003-05-20 | 2005-01-06 | Transtech Pharma, Inc. | Rage antagonists as agents to reverse amyloidosis and diseases associated therewith |
| CN101468970B (zh) * | 2008-04-25 | 2011-05-11 | 暨南大学 | 一种硝酮类化合物及其制备方法和在制药中的应用 |
| JP5805646B2 (ja) | 2009-09-30 | 2015-11-04 | ブイティーブイ・セラピューティクス・エルエルシー | アルツハイマー病の治療のための置換イミダゾール誘導体 |
| JP5885620B2 (ja) * | 2012-08-22 | 2016-03-15 | 四国化成工業株式会社 | ２−（２−フリル）イミダゾール化合物及び酸化防止剤 |
| FR3012458B1 (fr) * | 2013-10-25 | 2015-10-30 | Michelin & Cie | Composition de caoutchouc comprenant un additif compose 1,3-dipolaire portant une fonction imidazole |
| FR3012451B1 (fr) | 2013-10-25 | 2016-11-11 | Michelin & Cie | Compose 1,3-dipolaire portant une fonction imidazole |
| FR3012460B1 (fr) | 2013-10-25 | 2015-12-11 | Michelin & Cie | Composition de caoutchouc comprenant un elastomere dienique portant des fonctions imidazole reparties de facon aleatoire le long de la chaine |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0643403B2 (ja) * | 1986-01-25 | 1994-06-08 | 四国化成工業株式会社 | イミダゾール―アルドキシム化合物の合成方法 |
| US4803282A (en) * | 1986-08-27 | 1989-02-07 | Pennwalt Corporation | Alpha-substituted ketonitrone derivatives |
| WO1992022290A1 (en) * | 1991-06-18 | 1992-12-23 | Oklahoma Medical Research Foundation | Use of spin trapping for the treatment of diseases associated with oxidation of lipids and proteins |
| US5455272A (en) * | 1993-10-22 | 1995-10-03 | Oklahoma Medical Research Foundation | Spin trap nitronyl hindered phenols |
| CA2235765C (en) * | 1995-11-17 | 2006-04-04 | David A. Becker | Azulenyl nitrone spin trapping agents, methods of making and using same |
-
1998
- 1998-06-26 FR FR9808116A patent/FR2780404B1/fr not_active Expired - Fee Related
-
1999
- 1999-06-04 CA CA002274621A patent/CA2274621C/fr not_active Expired - Fee Related
- 1999-06-22 JP JP11175839A patent/JP2000026428A/ja active Pending
- 1999-06-23 NO NO19993122A patent/NO312722B1/no not_active IP Right Cessation
- 1999-06-24 EP EP99401565A patent/EP0967207B1/de not_active Expired - Lifetime
- 1999-06-24 AT AT99401565T patent/ATE223904T1/de not_active IP Right Cessation
- 1999-06-24 DK DK99401565T patent/DK0967207T3/da active
- 1999-06-24 ES ES99401565T patent/ES2183492T3/es not_active Expired - Lifetime
- 1999-06-24 DE DE69902851T patent/DE69902851T2/de not_active Expired - Fee Related
- 1999-06-24 PT PT99401565T patent/PT967207E/pt unknown
- 1999-06-25 AU AU36800/99A patent/AU747203B2/en not_active Ceased
- 1999-06-25 NZ NZ336460A patent/NZ336460A/xx unknown
- 1999-06-25 ZA ZA9904201A patent/ZA994201B/xx unknown
- 1999-06-25 CN CNB991112148A patent/CN1153766C/zh not_active Expired - Fee Related
- 1999-06-25 BR BR9903282-1A patent/BR9903282A/pt not_active IP Right Cessation
- 1999-06-25 US US09/340,088 patent/US6034250A/en not_active Expired - Fee Related
- 1999-06-25 HU HU9902199A patent/HUP9902199A1/hu not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000026428A (ja) | 2000-01-25 |
| CA2274621C (fr) | 2004-01-20 |
| FR2780404B1 (fr) | 2001-04-13 |
| AU3680099A (en) | 2000-01-13 |
| HUP9902199A1 (hu) | 2000-06-28 |
| PT967207E (pt) | 2002-12-31 |
| CN1245169A (zh) | 2000-02-23 |
| NO993122D0 (no) | 1999-06-23 |
| CN1153766C (zh) | 2004-06-16 |
| FR2780404A1 (fr) | 1999-12-31 |
| EP0967207B1 (de) | 2002-09-11 |
| NZ336460A (en) | 2000-05-26 |
| ZA994201B (en) | 2000-01-11 |
| AU747203B2 (en) | 2002-05-09 |
| DE69902851D1 (de) | 2002-10-17 |
| EP0967207A1 (de) | 1999-12-29 |
| BR9903282A (pt) | 2000-04-18 |
| HU9902199D0 (en) | 1999-08-30 |
| NO993122L (no) | 1999-12-27 |
| ES2183492T3 (es) | 2003-03-16 |
| NO312722B1 (no) | 2002-06-24 |
| DK0967207T3 (da) | 2003-01-20 |
| US6034250A (en) | 2000-03-07 |
| CA2274621A1 (fr) | 1999-12-26 |
| DE69902851T2 (de) | 2003-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE185807T1 (de) | Thiazolylbenzofuranderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die sie enthalten | |
| ATE144503T1 (de) | Thiazolidin-2,4-dionderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| ATE126216T1 (de) | Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung. | |
| ATE223904T1 (de) | Nitronderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| KR860004894A (ko) | 벤조옥사졸- 및 벤조티아졸아민 유도체의 제조방법 | |
| DE69010232D1 (de) | 2-(1-Piperazinyl)-4-phenylcycloalkanpyridin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten. | |
| TW333527B (en) | Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them | |
| ATE117304T1 (de) | Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel. | |
| KR970704444A (ko) | 트리아진 유도체 및 의약(triazine derivative and medicine) | |
| ATE240306T1 (de) | Benzothiadiazinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| PT83725B (pt) | Processo para preparacao de novos derivados da 3-oxadiol-beta-carbolina e 3-carboxilato-beta-carbolina e de composicoes farmaceuticas que os contem | |
| PT99502A (pt) | Processo para a preparacao de novos derivados de imidazol | |
| ATE41659T1 (de) | Benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen. | |
| ATE23715T1 (de) | Neue 1-acetonyl-2-(phenylimino)-imidazolidine, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung. | |
| ATE281452T1 (de) | 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
| DE69024154D1 (de) | Pyrimidoindolderivate und Verfahren zu ihrer Herstellung | |
| ATE28457T1 (de) | (5-(2-aminomethyl-imidazol-1-yl)-1,3-dialkyl-1h pyrazol-4-yl)(aryl)methanone und verfahren zu deren herstellung. | |
| ATE117682T1 (de) | Substituierte benzothiazolinone, ihre herstellung und sie enthaltende pharmazeutische zusammenstellungen. | |
| DE3860117D1 (de) | 2,3-dihydro-3-phenyl-benzofuran-2-on-acetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0967207 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |